# Carolyn S. Calfee

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/carolyn-s-calfee/

## Facts

| Field | Value |
| --- | --- |
| Citations | 37,769 |
| Field | Respiratory Support and Mechanisms |
| h-index | 94 |
| i10-index | 278 |
| Last Known Institution | University of California, San Francisco |
| OpenAlex ID | https://openalex.org/A5062212651 |
| ORCID iD | https://orcid.org/0000-0001-9208-6865 |
| Works | 498 |

## Researcher papers

- [Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials](https://scholariq.org/papers/subphenotypes-in-acute-respiratory-distress-syndrome-latent-class-analysis-of/)
- [Practitioner’s Guide to Latent Class Analysis: Methodological Considerations and Common Pitfalls](https://scholariq.org/papers/practitioner-s-guide-to-latent-class-analysis-methodological-considerations-and/)
- [A living WHO guideline on drugs for covid-19 (2020-2023)](https://scholariq.org/papers/a-living-who-guideline-on-drugs-for-covid-19-2020-2023/)
- [ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies](https://scholariq.org/papers/esicm-guidelines-on-acute-respiratory-distress-syndrome-definition-phenotyping/)
- [Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy](https://scholariq.org/papers/acute-respiratory-distress-syndrome-subphenotypes-respond-differently-to/)
- [Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial](https://scholariq.org/papers/acute-respiratory-distress-syndrome-subphenotypes-and-differential-response-to/)
- [A New Global Definition of Acute Respiratory Distress Syndrome](https://scholariq.org/papers/a-new-global-definition-of-acute-respiratory-distress-syndrome/)
- [Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial](https://scholariq.org/papers/treatment-with-allogeneic-mesenchymal-stromal-cells-for-moderate-to-severe-acute/)
- [Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study](https://scholariq.org/papers/latent-class-analysis-of-ards-subphenotypes-a-secondary-analysis-of-the-statins/)
- [Plasma Angiopoietin-2 Predicts the Onset of Acute Lung Injury in Critically Ill Patients](https://scholariq.org/papers/plasma-angiopoietin-2-predicts-the-onset-of-acute-lung-injury-in-critically-ill/)

## Researcher topics

- [Respiratory Support and Mechanisms](https://scholariq.org/topics/respiratory-support-and-mechanisms/)
- [Sepsis Diagnosis and Treatment](https://scholariq.org/topics/sepsis-diagnosis-and-treatment/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Intensive Care Unit Cognitive Disorders](https://scholariq.org/topics/intensive-care-unit-cognitive-disorders/)
- [Neonatal Respiratory Health Research](https://scholariq.org/topics/neonatal-respiratory-health-research/)

## Researcher university

- [University of California, San Francisco](https://scholariq.org/institutions/university-of-california-san-francisco/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.